AVEO PHARMACEUTICALS INC Uncategorized Contracts & Agreements

24 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Offer Letter by the Registrant to Jebediah Ledell, dated November 12, 2021
AVEO PHARMACEUTICALS INC
Biotechnology
2022
Offer Letter by the Registrant to Michael Ferraresso, dated April 8, 2021
AVEO PHARMACEUTICALS INC
Biotechnology
2022
Offer Letter by and between the Registrant and Erick Lucera, dated December 12, 2019
AVEO PHARMACEUTICALS INC
Biotechnology
2020
Description of Registered Securities
AVEO PHARMACEUTICALS INC
Biotechnology
2020
Agreement, dated December 18, 2018, by and between the Registrant and Novartis International Pharmaceutical Ltd
AVEO PHARMACEUTICALS INC
Biotechnology
MA
2019
Offer Letter by and between the Registrant and Karuna Rubin dated June 16, 2015
AVEO PHARMACEUTICALS INC
Biotechnology
2019
Offer Letter by and between the Registrant and Nikhil Mehta, dated November 10, 2017
AVEO PHARMACEUTICALS INC
Biotechnology
2018
EXHIBIT A INVENTION AND NON-DISCLOSURE AGREEMENT
AVEO PHARMACEUTICALS INC
Biotechnology
2017
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions.
AVEO PHARMACEUTICALS INC
Biotechnology
2016
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions
AVEO PHARMACEUTICALS INC
Biotechnology
DE
2016
Page 1 of 2
AVEO PHARMACEUTICALS INC
Biotechnology
2016
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions.
AVEO PHARMACEUTICALS INC
Biotechnology
NY
2015
Page 1 of 2
AVEO PHARMACEUTICALS INC
Biotechnology
2015
Confidential Materials omitted and filed separately withthe Securities and Exchange Commission. Double asterisks denote omissions.
AVEO PHARMACEUTICALS INC
Biotechnology
NY
2015
[AVEO PHARMACEUTICALS LETTERHEAD]
AVEO PHARMACEUTICALS INC
Biotechnology
2014
Confidential Materials omitted and filed separately withthe Securities and Exchange Commission. Double asterisks denote omissions.
AVEO PHARMACEUTICALS INC
Biotechnology
DE
2014
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions.
AVEO PHARMACEUTICALS INC
Biotechnology
2014
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions.
AVEO PHARMACEUTICALS INC
Biotechnology
DE
2014
[AVEO PHARMACEUTICALS LETTERHEAD]
AVEO PHARMACEUTICALS INC
Biotechnology
2014
[AVEO PHARMACEUTICALS LETTERHEAD]
AVEO PHARMACEUTICALS INC
Biotechnology
2014
Confidential Materials omitted and filedseparately with the Securities and Exchange Commission. Asterisks denote omissions.
AVEO PHARMACEUTICALS INC
Biotechnology
NY
2010
Confidential Materials omitted and filedseparately with the Securities and Exchange Commission. Asterisks denote omissions.
AVEO PHARMACEUTICALS INC
Biotechnology
NY
2009
Confidential Materials omitted and filedseparately with the Securities and Exchange Commission. Asterisks denote omissions.
AVEO PHARMACEUTICALS INC
Biotechnology
MA
2009
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions.
AVEO PHARMACEUTICALS INC
Biotechnology
NY
2009